Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Aquis weekly movers: SulNOx Group signs new shipping agreement

AIM movers: New lease of life for Fiinu

AIM Movers: Quantum Blockchain Technologies breakthrough and IG Design Christmas slump

Further upgrade for Concurrent Technologies as design wins boost long-term growth

Trustpilot beats 2024 expectations

AIM movers: Celadon Pharmaceuticals collaboration progress and Deltex Medical leaving AIM

AIM movers: Fiinu secures first Plugin Overdraft customer and Distil sales slump

AIM movers: Trellus Health partners with Johnson & Johnson and Thruvision strategic review

AIM movers: Eagle Eye short-term sales stall and Jubilee Metals signs Zambia power agreement

Director deals: Iomart restructuring provides reason for optimism

Aquis weekly movers: Good Life Plus fundraising

AIM weekly movers: ImmuPharma trebles on positive research news

AIM movers: DBAY bids for Alliance Pharma and Enteq shares slide by nearly three-quarters due to delays

AIM movers: ImmuPharma autoimmune therapy success and ex-dividends

ProCook recovery accelerates

AIM movers: Mkango Resources intends to spin off assets in Nasdaq shell and RBG terminates Ian Rosenblatt consultancy

AIM movers: Team Internet approach and Global Petroleum funding

AIM movers: Arrow Exploration drilling continues and Hercules Site Services to sell division

New AIM admission: Pri0r1ty Intelligence has much to prove

Aquis weekly movers: Global Connectivity invests in decommissioning copper cables

AIM weekly movers: Fusion Antibodies chart indicates rise and potential Poolbeg Pharma merger sparks share price drop

Tullow Oil wins tax case

AIM movers: Volex acquisition beats target and Revolution Beauty continues recovery

AIM movers: Revolution Beauty settlement and potential Nasdaq merger for Poolbeg Pharma

Why companies left AIM in December 2024

Hutchison (China) builds cash pile with joint venture stake disposal

Why companies left AIM in November 2024

DG Innovate reveals delisting plan

AIM movers: ValiRx extends exclusivity period and ADM Energy returns from suspension

Why companies left AIM in October 2024

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020